Abstract
Objective To observe the propranolol and the 5-isosorbide mononitrate to prevent the prevention of esophageal variceal hemorrhage. Methods 36 cases of treatment group and control group 32 patients were compared The rebleeding situation of two groups were observed. Results The treatment group were followed up for two years in rebleeding rate was significantly lower than the control group(P＜ 0. 01). Conclusion Propranolol and 5-isosorbide mononitrate can prevent esophageal varices rebleeding incidence. Key words: Propranolol; 5-isosorbide mononitrate; Esophageal variceal rebleeding; Clinical efficacy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
